Alkermes plc
ALKS
Classificação em ações
#2597
Alkermes plc, a biopharmaceutical company, engages in the research,... Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Preço da ação
$43.85
Valor de mercado
$7.36B
Variação (1 dia)
-0.59%
Variação (1 ano)
39.43%
País
IE
Negociar Alkermes plc (ALKS)
Categoria
Healthcare
Histórico de preços das ações de Alkermes plc (ALKS)
Preço de fecho mais alto: $41.35 em 2026-10-01
Preço de fecho mais baixo: $5.16 em 1991-07-01
Preço de fecho mais baixo: $5.16 em 1991-07-01
Histórico de preços das ações da Alkermes plc de 1991 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | 31.77% |
| 2025 | -5.27% |
| 2024 | 11.89% |
| 2023 | 5.82% |
| 2022 | 11.46% |
| 2021 | 11.60% |
| 2020 | -1.81% |
| 2019 | -34.83% |
| 2018 | -39.69% |
| 2017 | -5.34% |
| 2016 | -25.70% |
| 2015 | 33.49% |
| 2014 | 40.87% |
| 2013 | 110.47% |
| 2012 | 17.80% |
| 2011 | 38.74% |
| 2010 | 27.92% |
| 2009 | -2.84% |
| 2008 | -37.96% |
| 2007 | 6.15% |
| 2006 | -21.96% |
| 2005 | 26.96% |
| 2004 | 12.48% |
| 2003 | 80.01% |
| 2002 | -71.44% |
| 2001 | -23.13% |
| 2000 | 39.57% |
| 1999 | 136.44% |
| 1998 | 5.32% |
| 1997 | 0.19% |
| 1996 | 173.62% |
| 1995 | 175.36% |
| 1994 | -68.53% |
| 1993 | -17.41% |
| 1992 | -38.13% |
| 1991 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $517.34 | 21.36% |
US
|
|
| $246.59 | 797.01% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $882.02 | 5.66% |
NL
|
|
| $752.87 | 7.40% |
CH
|
